Jul 16, 2024, 23:11
The role of TP53 and ctDNA kinetics in patients with R/R DLBCL
VJHemOnc (The Video Journal of Hematology and Hematological Oncology) shared a post on X:
”In an insightful recent interview, Carmelo Carlo-Stella (Humanitas University) speaks on the role of TP53 and ctDNA kinetics in patients with relapsed or refractory diffuse large B-cell lymphoma treated with glofitamab monotherapy. Watch here.”
Source: VJHemOnc/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18